Ophthalmology Innovation Summit @ AAO Logo 2014 OIS@AAO
October 16, 2014 | Chicago, IL
Register

Thank you to all that attended! Hope to see you all at the 2015 OIS@AAO in Las Vegas.

The Ophthalmology Innovation Summit was created to facilitate meaningful interactions and business partnerships between physicians, entrepreneurs, investors and industry executives who are driving ophthalmic innovation. OIS addresses key issues – both hurdles and opportunities while showcasing the most promising private ophthalmic companies.

Palmer House Hilton

Reserve a Room for OIS@AAO 2014:

Discounted room rates have been negotiated exclusively for AAO 2014 Attendees. There is limited inventory available at these special rates so we urge you to book today!

Start Networking Today… Get The App!

OIS App for iPhone OIS App for iPad OIS App for Android

Or access the mobile or desktop version.

Latest News

Dorit Donoviel on Space & Ophthalmology

Visual Disorders In Space And How Ophthalmology Can Help

Jeff George Q&A at OIS@AAO

Jeff George’s Vision for Innovation at Alcon

Laurent Attias Q&A at OIS@AAO

Laurent Attias Explains How Alcon Will Maximize the Ora System’s Potential

Tom Frinzi Q&A at OIS@AAO

WaveTec CEO Tom Frinzi Hints at Plans for Future

Tom Salemi - Jeff George Newscast

Alcon’s George Stresses Innovation

Tom Salemi Google Newscast

Google Eyes Ophthalmology

Tom Salemi IPO Newscast

CEOs Share Lessons from IPOs

Tom Salemi M&A Newscast

How to Do M&A Well

Michael Brownell Q&A at OIS@AAO

Q&A with Michael Brownell

Richard Lindstrom Q&A at OIS@AAO

Q&A with Richard Lindstrom

Jeffery Hoffman on The Ophthalmology Market

The Ophthalmology Market – A View Of The Public Sector & Exit Trends

Reinventing Your Company - Panel Discussion

Second Acts – Reinventing Your Company

Jonathan Norris on Private Funding Trends in Healthcare

Private Funding Trends In Healthcare

A Veiw from the NEI with Matthew McMahon

A View From The NEI – Ophthalmic Innovation in 2014

David W. Parke - View from the AAO

A View From The AAO – Ophthalmic Innovation in 2014

2014 OIS Award AGTC Founders

2014 OIS Innovator Award Presentation

FDA Q&A - Malvina & Wiley

FDA Q&A

Doug Foster of DigiSight

DigiSight

Tom Brogan of Vestrum Health

Vestrum Health

Harvey Fishman of AppVisit

AppVisit

Noel Alpins of Assort

Assort

Michael Brownell of Gobiquity

Gobiquity

Richard Awdeh of CheckedUp

CheckedUp

Jeroen Cammeraat of i-Optics

i-Optics

Tom Frinzi of WaveTec Vision Systems

WaveTec Vision Systems

Tim Willis of TearScience

TearScience

Barry Cheskin of PowerVision

PowerVision

Quinton Oswald of Neurotech

Neurotech

Robert Butchofsky of Mati Therapeutics

Mati Therapeutics

Ronen Castro of IOPtima

IOPtima

Max Ostermeier of Implandata Ophthalmic Products GmbH

Implandata Ophthalmic Products GmbH

John Maroney of ForSight VISION5

ForSight VISION5

David Muller of Avedro

Avedro

Russell Trenary of InnFocus

InnFocus

Dan Myers of Alimera Sciences

Alimera Sciences

ois

Device, Delivery, & Diagnostic Company Showcase

jeff george

Alcon’s George Shares Passion for Ophthalmology

Untitled-1

Biopharma Companies of All Stages Shine in OIS Showcase

hoffman

Eye Companies Helping Health Care Stand Out

second acts

CEOs Share Their ‘Second Acts’ On Way to Building Successful Companies

fda

FDA Division Directors Detail How Agency Adapts to Innovation

ois

Digital Health Companies Poised to Grow

David W. Parke Pic

AAO Sees Good and Bad in Consolidation

Matthew J. McMahon Pic

The NEI’s Role in Innovation

Franz Obermayr of Panoptes

Panoptes Developing Inhibitor For Local Treatments In Ocular Disease

Shelly Boyd of Translatum Medicus

Translatum Medicus Developing Option To Treat Dry AMD

Charlie McDermott of Kala Pharmaceuticals

Kala Pharmaceuticals Offers Glimpse Into Preclinical Pipeline

John Freshly of ONL

ONL Therapeutics Develops Novel Mechanism To Attack Fas Receptor Apoptosis

Page 1 of 212
Share with your friends










Submit